These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 1550172)

  • 1. Oral contraceptive type and functional ovarian cysts.
    Lanes SF; Birmann B; Walker AM; Singer S
    Am J Obstet Gynecol; 1992 Mar; 166(3):956-61. PubMed ID: 1550172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phasic contraceptive pills and functional ovarian cysts.
    Caillouette JC; Koehler AL
    Am J Obstet Gynecol; 1987 Jun; 156(6):1538-42. PubMed ID: 3296761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptive formulation and ovarian cysts: FDA committee finds no increased risk of follicular enlargement with low-dose monophasic or triphasic preparations.
    Contracept Rep; 1994 Mar; 5(1):6-9. PubMed ID: 12287739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benefits and risks of oral contraceptive use.
    Williams RS
    Postgrad Med; 1992 Nov; 92(7):155-7, 161-2, 168-71. PubMed ID: 1437913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives: a reassessment.
    Derman R
    Obstet Gynecol Surv; 1989 Sep; 44(9):662-8. PubMed ID: 2671844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    Fertil Steril; 1998 Dec; 70(6):1063-9. PubMed ID: 9848296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and benign gynecologic conditions. A review.
    Chiaffarino F; Parazzini F; La Vecchia C; Ricci E; Crosignani PG
    Contraception; 1998 Jan; 57(1):11-8. PubMed ID: 9554245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.
    Holt VL; Daling JR; McKnight B; Moore D; Stergachis A; Weiss NS
    Obstet Gynecol; 1992 Apr; 79(4):529-33. PubMed ID: 1553170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety implications of transferring the oral contraceptive from prescription-only to over-the-counter status.
    Potts M; Denny C
    Drug Saf; 1995 Dec; 13(6):333-7. PubMed ID: 8652077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
    Biljan MM; Mahutte NG; Dean N; Hemmings R; Bissonnette F; Tan SL
    J Assist Reprod Genet; 1998 Nov; 15(10):599-604. PubMed ID: 9866068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives. Who, which, when, and why?
    Marut EL
    Postgrad Med; 1987 Sep; 82(4):66-70. PubMed ID: 3628138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary infertility and oral contraceptive steroid use.
    Bagwell MA; Thompson SJ; Addy CL; Coker AL; Baker ER
    Fertil Steril; 1995 Jun; 63(6):1161-6. PubMed ID: 7750582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of oral contraceptives: epidemiologic insights from the first 30 years.
    Grimes DA
    Am J Obstet Gynecol; 1992 Jun; 166(6 Pt 2):1950-4. PubMed ID: 1605284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose monophasic oral contraceptive pills and expectant management in treatment of functional ovarian cysts.
    Sanersak S; Wattanakumtornkul S; Korsakul C
    J Med Assoc Thai; 2006 Jun; 89(6):741-7. PubMed ID: 16850671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Choosing the best oral contraceptive.
    Stubblefield PG
    Clin Obstet Gynecol; 1989 Jun; 32(2):316-28. PubMed ID: 2743645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K; Rolland R; Brosens I; Moorrees M; Deprest J; Tuominen J; Lähteenmäki P
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional ovarian cysts in premenopausal and gynecologically healthy women.
    Christensen JT; Boldsen JL; Westergaard JG
    Contraception; 2002 Sep; 66(3):153-7. PubMed ID: 12384202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.